Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism caspase 3 inhibitors(Caspase-3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | CA | 30 Jan 2022 | |
Brain Injuries, Traumatic | Preclinical | CA | 30 Jan 2022 | |
Multiple Sclerosis | Preclinical | CA | 30 Jan 2022 | |
Parkinson Disease | Preclinical | CA | 30 Jan 2022 | |
Spinal Cord Injuries | Preclinical | CA | 30 Jan 2022 | |
Stroke | Preclinical | CA | 30 Jan 2022 | |
Myocardial Infarction | Preclinical | CA | - | |
Neoplasms | Preclinical | CA | - |